222 related articles for article (PubMed ID: 10718807)
21. Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer.
Lee JH; Choi MG; Min BH; Noh JH; Sohn TS; Bae JM; Kim S
Br J Surg; 2012 Dec; 99(12):1688-92. PubMed ID: 23023388
[TBL] [Abstract][Full Text] [Related]
22. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.
Maehara Y; Kakeji Y; Oda S; Takahashi I; Akazawa K; Sugimachi K
Br J Cancer; 2000 Oct; 83(8):986-91. PubMed ID: 10993643
[TBL] [Abstract][Full Text] [Related]
23. Node dissection in gastric cancer.
de Aretxabala X; Konishi K; Yonemura Y; Ueno K; Yagi M; Noguchi M; Miwa K; Miyazaki I
Br J Surg; 1987 Sep; 74(9):770-3. PubMed ID: 3664236
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of lymph node dissection in gastric cancer.
de Manzoni G; Verlato G; Guglielmi A; Laterza E; Genna M; Cordiano C
Br J Surg; 1996 Nov; 83(11):1604-7. PubMed ID: 9014687
[TBL] [Abstract][Full Text] [Related]
25. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.
Sakar B; Karagol H; Gumus M; Basaran M; Kaytan E; Argon A; Ustuner Z; Bavbek SE; Bugra D; Aykan FN
Am J Clin Oncol; 2004 Apr; 27(2):205-9. PubMed ID: 15057162
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
27. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.
Lee JH; Paik YH; Lee JS; Song HJ; Ryu KW; Kim CG; Park SR; Kook MC; Kim YW; Bae JM
Ann Surg Oncol; 2006 Sep; 13(9):1163-7. PubMed ID: 16952027
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic analysis of 280 patients with T4a gastric cancer who underwent curative resection].
Gao WF; Liang H; Deng JY; Wang DC; Zhang RP
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Dec; 15(12):1261-4. PubMed ID: 23268273
[TBL] [Abstract][Full Text] [Related]
30. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time.
Maehara Y; Okuyama T; Moriguchi S; Orita H; Kusumoto H; Korenaga D; Sugimachi K
Cancer; 1992 Jul; 70(2):392-5. PubMed ID: 1617589
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting recurrence in node-negative advanced gastric cancer.
Huang KH; Chen JH; Wu CW; Lo SS; Hsieh MC; Li AF; Lui WY
J Gastroenterol Hepatol; 2009 Sep; 24(9):1522-6. PubMed ID: 19467143
[TBL] [Abstract][Full Text] [Related]
33. [Clinico-pathological study on recurrent gastric cancer after curative resection].
Takeshita K; Habu H; Sunagawa M; Saitoh N; Satoh Y; Endoh M
Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):173-80. PubMed ID: 2834631
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients.
Zhao B; Huang X; Zhang J; Luo R; Lu H; Xu H; Huang B
Rev Esp Enferm Dig; 2019 Feb; 111(2):111-120. PubMed ID: 30404528
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
38. The patterns and timing of recurrence after curative resection for gastric cancer in China.
Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer.
Gotoda T; Sasako M; Ono H; Katai H; Sano T; Shimoda T
Br J Surg; 2001 Mar; 88(3):444-9. PubMed ID: 11260114
[TBL] [Abstract][Full Text] [Related]
40. Prediction of lymph node metastasis by size of early gastric carcinoma.
Otsuji E; Kuriu Y; Ichikawa D; Ochiai T; Okamoto K; Yamagishi H
Hepatogastroenterology; 2007 Mar; 54(74):602-5. PubMed ID: 17523331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
